Financials
Financial year 2025
HOSPIPLAN from Schaarbeek, company number BE0459516615, closed financial year 2025 with a result of € -205,799 after tax. For that financial year HOSPIPLAN recorded a gross margin of € 50,493 and equity of € 5.2 million. Compared with financial year 2024, the result moved from € 566,554 to € -205,799. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on December 12, 2025.
€ 5.2 million
▼ 4% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -205,799
▼ still € 566,554 profit in 2024
Profit after tax over the fiscal year.
€ 271,809
▼ 10% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -1.3 million.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 70,536
▼ 44% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 7,184
▼ 77% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 31,175 | € 58,966 | € 94,701 | € 50,493 | ▼ 47% |
| Profit after taxes | € -33,116 | € 14,731 | € 566,554 | € -205,799 | ▼ € 772,353 |
| Equity | € 4,834,402 | € 4,849,133 | € 5,415,687 | € 5,209,887 | ▼ 4% |
| Total debts | € 49,981 | € 96,588 | € 157,761 | € 77,720 | ▼ 51% |
| Cash | € 243,711 | € 301,339 | € 303,564 | € 271,809 | ▼ 10% |
| Retained profit | € -1,680,848 | € -1,666,117 | € -1,099,563 | € -1,305,363 | ▼ € 205,799 |
| Balance sheet total | € 4,884,383 | € 4,945,721 | € 5,573,448 | € 5,287,607 | ▼ 5% |
By gross margin, HOSPIPLAN ranks 8th of 9 companies with main activity “Groothandel in farmaceutische en medische artikelen” in Schaarbeek that publish figures (fiscal year 2025).
Key figures of HOSPIPLAN, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 January 2027.
Ask about HOSPIPLAN the way you would ask their accountant.
Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.
Connect ChatGPT or Claude for free- ChatGPT
- Claude
Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.
What happened to HOSPIPLAN?
What happened at HOSPIPLAN in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 205,799 (▼ € 772,353 vs 2024). Source: NBB ↗
- Laurence NOOTENS became a director. NBB
- Pierre-Henri NOOTENS became a director. NBB
- Valérie NOOTENS became a director. NBB
- New establishment in Schaarbeek. KBO
- Start of the company according to the CBE. KBO
In short
From € 33,116 loss in 2022 to € 205,799 loss in 2025.
Paid € 57,826 in corporate taxes since 2022.
Best year ever: 2024, with € 566,554 profit.
Management
Behind HOSPIPLAN are Laurence NOOTENS , Pierre-Henri NOOTENS and Valérie NOOTENS. It owns 99.1% of ETABLISSEMENTS HENRI NOOTENS SA itself.
Directors
According to the 2025 annual accounts
Laurence NOOTENS
Director
since 2023
Pierre-Henri NOOTENS
Director
since 2023
Valérie NOOTENS
Director
since 2023
Establishments
Establishment units
Physical locations of this company
Georges Rodenbachlaan 75
1030 Schaarbeek
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Similar companies in Schaarbeek
Same main activity (Groothandel in farmaceutische en medische artikelen), 14 active companies in Schaarbeek, largest first.
€ 136.2 million revenue · 2026
€ 16.9 million revenue · 2025
€ 4.9 million revenue · 2025
€ 1.6 million gross margin · 2025
€ 1 million gross margin · 2025
€ 785,538 gross margin · 2025
Details
- Company number
- 0459.516.615
- VAT number
- BE 0459.516.615
- Registered office
- Georges Rodenbachlaan 75, 1030 Schaarbeek
- Names & denominations
- HOSPIPLAN
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 20 December 1996
- Peppol
- Active · Active since 30 Dec 2025
- Activities · NACE
Groothandel in farmaceutische en medische artikelen
Groothandel in farmaceutische producten
Detailhandel in medische en orthopedische artikelen, muv corrigerende brillen, lenzen en zonnebrillen
Detailhandel in medische en orthopedische artikelen
Detailhandel in medische en orthopedische artikelen in gespecialiseerde winkels